Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Cerebrovascular Injury After Serial Exposure to Chronic Stress and Abstinence from Methamphetamine Self-Administration.

Natarajan R, Mitchell CM, Harless N, Yamamoto BK.

Sci Rep. 2018 Jul 12;8(1):10558. doi: 10.1038/s41598-018-28970-1.

2.

Mechanisms Regulating the Association of Protein Phosphatase 1 with Spinophilin and Neurabin.

Edler MC, Salek AB, Watkins DS, Kaur H, Morris CW, Yamamoto BK, Baucum AJ 2nd.

ACS Chem Neurosci. 2018 Jun 1. doi: 10.1021/acschemneuro.8b00144. [Epub ahead of print]

PMID:
29786422
3.

Methamphetamine-Induced Brain Injury and Alcohol Drinking.

Blaker AL, Yamamoto BK.

J Neuroimmune Pharmacol. 2018 Mar;13(1):53-63. doi: 10.1007/s11481-017-9764-3. Epub 2017 Aug 30.

PMID:
28856500
4.

Chronic-Stress-Induced Behavioral Changes Associated with Subregion-Selective Serotonin Cell Death in the Dorsal Raphe.

Natarajan R, Forrester L, Chiaia NL, Yamamoto BK.

J Neurosci. 2017 Jun 28;37(26):6214-6223. doi: 10.1523/JNEUROSCI.3781-16.2017. Epub 2017 May 25.

5.

Disruption of the Glutamate-Glutamine Cycle Involving Astrocytes in an Animal Model of Depression for Males and Females.

Rappeneau V, Blaker A, Petro JR, Yamamoto BK, Shimamoto A.

Front Behav Neurosci. 2016 Dec 6;10:231. doi: 10.3389/fnbeh.2016.00231. eCollection 2016.

6.

MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.

Huff CL, Morano RL, Herman JP, Yamamoto BK, Gudelsky GA.

Neurotoxicology. 2016 Dec;57:282-290. doi: 10.1016/j.neuro.2016.10.011. Epub 2016 Oct 20.

7.

Peripheral ammonia and blood brain barrier structure and function after methamphetamine.

Northrop NA, Halpin LE, Yamamoto BK.

Neuropharmacology. 2016 Aug;107:18-26. doi: 10.1016/j.neuropharm.2016.03.018. Epub 2016 Mar 10.

8.

3,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling.

Collins SA, Huff C, Chiaia N, Gudelsky GA, Yamamoto BK.

J Neurochem. 2016 Mar;136(5):1074-84. doi: 10.1111/jnc.13493. Epub 2016 Jan 19.

9.

Protracted effects of chronic stress on serotonin-dependent thermoregulation.

Natarajan R, Northrop NA, Yamamoto BK.

Stress. 2015;18(6):668-76. doi: 10.3109/10253890.2015.1087502. Epub 2015 Sep 28.

10.

Behavioral impairments and serotonin reductions in rats after chronic L-dopa.

Stansley BJ, Yamamoto BK.

Psychopharmacology (Berl). 2015 Sep;232(17):3203-13. doi: 10.1007/s00213-015-3980-4. Epub 2015 Jun 3.

11.

Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats.

Das SC, Yamamoto BK, Hristov AM, Sari Y.

Neuropharmacology. 2015 Oct;97:67-74. doi: 10.1016/j.neuropharm.2015.05.009. Epub 2015 May 19.

12.

MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors.

Collins SA, Gudelsky GA, Yamamoto BK.

Eur J Pharmacol. 2015 Aug 15;761:95-100. doi: 10.1016/j.ejphar.2015.04.035. Epub 2015 Apr 30.

13.

Methamphetamine effects on blood-brain barrier structure and function.

Northrop NA, Yamamoto BK.

Front Neurosci. 2015 Mar 4;9:69. doi: 10.3389/fnins.2015.00069. eCollection 2015. Review.

14.

L-Dopa and Brain Serotonin System Dysfunction.

Stansley BJ, Yamamoto BK.

Toxics. 2015 Mar 5;3(1):75-88. doi: 10.3390/toxics3010075. Review.

15.

Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus.

Stansley BJ, Yamamoto BK.

J Pharmacol Exp Ther. 2014 Nov;351(2):440-7. doi: 10.1124/jpet.114.218966. Epub 2014 Sep 11.

16.

Effects of stress and MDMA on hippocampal gene expression.

Weber GF, Johnson BN, Yamamoto BK, Gudelsky GA.

Biomed Res Int. 2014;2014:141396. doi: 10.1155/2014/141396. Epub 2014 Jan 9.

17.

Ammonia mediates methamphetamine-induced increases in glutamate and excitotoxicity.

Halpin LE, Northrop NA, Yamamoto BK.

Neuropsychopharmacology. 2014 Mar;39(4):1031-8. doi: 10.1038/npp.2013.306. Epub 2013 Oct 29.

18.

Methamphetamine causes acute hyperthermia-dependent liver damage.

Halpin LE, Gunning WT, Yamamoto BK.

Pharmacol Res Perspect. 2013 Oct;1(1):e00008. doi: 10.1002/prp2.8. Epub 2013 Oct 1.

19.

Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Halpin LE, Collins SA, Yamamoto BK.

Life Sci. 2014 Feb 27;97(1):37-44. doi: 10.1016/j.lfs.2013.07.014. Epub 2013 Jul 24. Review.

20.

Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.

Northrop NA, Yamamoto BK.

Neuropharmacology. 2013 Sep;72:96-105. doi: 10.1016/j.neuropharm.2013.04.040. Epub 2013 May 2.

Supplemental Content

Loading ...
Support Center